194 related articles for article (PubMed ID: 28731152)
1. AEG-1 associates with metastasis in papillary thyroid cancer through upregulation of MMP2/9.
Huang LL; Wang Z; Cao CJ; Ke ZF; Wang F; Wang R; Luo CQ; Lu X; Wang LT
Int J Oncol; 2017 Sep; 51(3):812-822. PubMed ID: 28731152
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-625-3p promotes the proliferation, migration and invasion of thyroid cancer cells by up-regulating astrocyte elevated gene 1.
Fang L; Kong D; Xu W
Biomed Pharmacother; 2018 Jun; 102():203-211. PubMed ID: 29558717
[TBL] [Abstract][Full Text] [Related]
3. Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways.
Guan H; Guo Z; Liang W; Li H; Wei G; Xu L; Xiao H; Li Y
BMC Cancer; 2017 Jul; 17(1):486. PubMed ID: 28709407
[TBL] [Abstract][Full Text] [Related]
4. AEG-1 induces gastric cancer metastasis by upregulation of eIF4E expression.
Wu S; Yang L; Wu D; Gao Z; Li P; Huang W; Wang X
J Cell Mol Med; 2017 Dec; 21(12):3481-3493. PubMed ID: 28661037
[TBL] [Abstract][Full Text] [Related]
5. Role of laminin 332 in lymph node metastasis of papillary thyroid carcinoma.
Oh KH; Choi J; Woo JS; Baek SK; Jung KY; Koh MJ; Kim YS; Kwon SY
Auris Nasus Larynx; 2017 Dec; 44(6):729-734. PubMed ID: 28238469
[TBL] [Abstract][Full Text] [Related]
6. Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.
Lv N; Shan Z; Gao Y; Guan H; Fan C; Wang H; Teng W
Endocrine; 2016 Mar; 51(3):469-77. PubMed ID: 26289126
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of MiR-431 expression associated with lymph node metastasis and promotes cell invasion in papillary thyroid carcinoma.
Liu Y; Li L; Liu Z; Yuan Q; Lu X
Cancer Biomark; 2018; 22(4):727-732. PubMed ID: 29945344
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of KDM1A suppresses tumour migration and invasion by epigenetically regulating the TIMP1/MMP9 pathway in papillary thyroid cancer.
Zhang W; Sun W; Qin Y; Wu C; He L; Zhang T; Shao L; Zhang H; Zhang P
J Cell Mol Med; 2019 Aug; 23(8):4933-4944. PubMed ID: 31211500
[TBL] [Abstract][Full Text] [Related]
9. MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.
Roncevic J; Djoric I; Selemetjev S; Jankovic J; Dencic TI; Bozic V; Cvejic D
Pathology; 2019 Jan; 51(1):55-61. PubMed ID: 30497805
[TBL] [Abstract][Full Text] [Related]
10. Activation of the ROCK1/MMP-9 pathway is associated with the invasion and poor prognosis in papillary thyroid carcinoma.
Luo D; Chen H; Li X; Lu P; Long M; Peng X; Lin S; Tan L; Zhu Y; Ouyang N; Li H
Int J Oncol; 2017 Oct; 51(4):1209-1218. PubMed ID: 28848996
[TBL] [Abstract][Full Text] [Related]
11. Astrocyte elevated gene-1 interacts with β-catenin and increases migration and invasion of colorectal carcinoma.
Zhang F; Yang Q; Meng F; Shi H; Li H; Liang Y; Han A
Mol Carcinog; 2013 Aug; 52(8):603-10. PubMed ID: 22431469
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
Wu G; Zhou Y; Li T; Guo J; Zhou Z
J Int Med Res; 2013 Jun; 41(3):816-24. PubMed ID: 23685894
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of pro-inflammatory genes and down-regulation of SOCS-1 in human PTC and in hypoxic BCPAP cells.
De Santis E; Di Vito M; Perrone GA; Mari E; Osti M; De Antoni E; Coppola L; Tafani M; Carpi A; Russo MA
Biomed Pharmacother; 2013 Feb; 67(1):7-16. PubMed ID: 23089475
[TBL] [Abstract][Full Text] [Related]
15. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
16. Expression of MMP-13 is associated with invasion and metastasis of papillary thyroid carcinoma.
Wang JR; Li XH; Gao XJ; An SC; Liu H; Liang J; Zhang K; Liu Z; Wang J; Chen Z; Sun W
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):427-35. PubMed ID: 23467939
[TBL] [Abstract][Full Text] [Related]
17. Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness.
Zhang T; Shen X; Liu R; Zhu G; Bishop J; Xing M
Oncotarget; 2017 Jan; 8(1):900-914. PubMed ID: 27863429
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
[TBL] [Abstract][Full Text] [Related]
19. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
Xue KC; Hu DD; Zhao L; Li N; Shen HY
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
[TBL] [Abstract][Full Text] [Related]
20. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
